Cementos Bio-Bio - Public Comps and Valuation Multiples

Cementos Bio-Bio Overview

About Cementos Bio-Bio

Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.

Founded

1957

HQ

Employees

2.9K+

Website

cementos.cl

Sectors

Building Materials

Financials

Last FY Revenue $375M

Last FY EBITDA $57.2M

EV

$506M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Cementos Bio-Bio Financials

See Cementos Bio-Bio valuation multiples based on analyst estimates

Cementos Bio-Bio P&L

In the most recent fiscal year, Cementos Bio-Bio reported revenue of $375M and EBITDA of $57.2M.

Cementos Bio-Bio expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cementos Bio-Bio valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$375M	XXX	XXX	XXX
Gross Profit	XXX	$143M	XXX	XXX	XXX
Gross Margin	XXX	38%	XXX	XXX	XXX
EBITDA	XXX	$57.2M	XXX	XXX	XXX
EBITDA Margin	XXX	15%	XXX	XXX	XXX
EBIT	XXX	$39.7M	XXX	XXX	XXX
EBIT Margin	XXX	11%	XXX	XXX	XXX
Net Profit	XXX	$33.8M	XXX	XXX	XXX
Net Margin	XXX	9%	XXX	XXX	XXX
Net Debt	XXX	$79.1M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Cementos Bio-Bio including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Cementos Bio-Bio achieved $375M in revenue and $57.2M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$375M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$143M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	38.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$57.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	15.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$39.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	10.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$33.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	9.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$79.1M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Cementos Bio-Bio

This financial data table provides comprehensive performance metrics for Cementos Bio-Bio, a company based in Chile. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Cementos Bio-Bio reported $375M in total revenue.
Fiscal year EBITDA was $57.2M.
The company maintained a gross profit margin of 38.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 15.3%.
Net profit margin reached 9.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Cementos Bio-Bio. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Cementos Bio-Bio Stock Performance

Cementos Bio-Bio has current market cap of CLP 483B (or $503M), and EV of CLP 485B (or $506M).

Market Cap Evolution

Cementos Bio-Bio Stock Data

As of October 2, 2025, Cementos Bio-Bio's stock price is CLP 1826 (or $2).

See Cementos Bio-Bio trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$506M	$503M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Cementos Bio-Bio Valuation Multiples

Cementos Bio-Bio's trades at 1.3x EV/Revenue multiple, and 8.8x EV/EBITDA.

See valuation multiples for Cementos Bio-Bio and 15K+ public comps

Cementos Bio-Bio Financial Valuation Multiples

As of October 2, 2025, Cementos Bio-Bio has market cap of $503M and EV of $506M.

Equity research analysts estimate Cementos Bio-Bio's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cementos Bio-Bio's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$503M	XXX	$503M	XXX	XXX	XXX
EV (current)	$506M	XXX	$506M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	1.3x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	8.8x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	12.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	14.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	9.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cementos Bio-Bio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Cementos Bio-Bio Margins & Growth Rates

Cementos Bio-Bio's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $36K for the same period.

Cementos Bio-Bio's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cementos Bio-Bio's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Cementos Bio-Bio and other 15K+ public comps

Cementos Bio-Bio Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	15%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$36K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	16%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	28%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial